Novel drug prevents common viral disease in stem-cell transplant patients ... Medical Xpress A new drug can often prevent a common, sometimes severe viral disease in patients receiving a transplant of donated blood-making stem cells, a clinical trial led by researchers at Dana-Farber Cancer Institute and Brigham and Women's Hospital indicates. Cytomegalovirus—a 'stealth' pathogen—gains attention in the drug development ... CMX001 reduced cytomegalovirus disease after HSCT |
